Medicare patients who suffer from type 1 or type 2 diabetes will now have access to Abbott Diabetes Care Inc.'s FreeStyle Libre, a new continuous glucose monitoring (CGM) system that eliminates the need for patients to employ routine fingersticks to check glucose levels, the company announced on Jan. 4.
The US Centers for Medicare and Medicaid Services' "recognition of this revolutionary health technology, which removes the need for any...






